Ken Griffin Electro Core, Inc. Transaction History

Citadel Advisors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.21 - $5.63 $21,093 - $565,510	100,446 New	100,446 $26,000
Q3 2021 Nov 15, 2021	BUY	$0.93 - $1.18 $36,157 - $45,877	38,879 Added 68.27%	95,832 $108,000
Q2 2021 Aug 16, 2021	SELL	$1.19 - $2.06 $251 - $434	-211 Reduced 0.37%	56,953 $67,000
Q1 2021 May 17, 2021	BUY	$1.62 - $3.05 $92,605 - $174,350	57,164 New	57,164 $118,000
Q3 2020 Nov 16, 2020	SELL	$0.8 - $2.33 $50,669 - $147,575	-63,337 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$0.75 - $1.29 $28,122 - $48,371	37,497 Added 145.11%	63,337 $52,000
Q2 2018 Aug 10, 2018	BUY	$16.51 - $19.85 $426,618 - $512,924	25,840 New	25,840 $0

143K

Ticker ECOR
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 71,176,896
Market Cap $1.09B
Description
electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults....

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.